Drafting Investment Memos
Investment memos are the core decision document for deploying capital. They synthesize diligence into a structured argument that enables an investment committee, board, or deal team to make a go/no-go decision with full awareness of the thesis, the risks, and the expected returns. The memo is not a summary — it is the decision artifact.
When To Use
- Preparing a deal for investment committee review (screening, LOI, or final IC)
- Writing a deal summary or recommendation for board presentation
- Documenting the investment rationale for a platform acquisition, add-on, growth investment, refinancing, IPO, or secondary transaction
- Creating a post-close retrospective memo evaluating realized vs. projected returns
- Supporting a fairness opinion or strategic alternatives analysis with structured deal analysis
Inputs To Gather
Confirm ALL of the following before drafting. Do not proceed with defaults — wrong audience framing invalidates the entire draft.
Deal Context (All Required)
| Field |
Notes |
| Company/Asset Name |
Legal name + common name if different |
| Asset Class |
Private equity, growth equity, credit, public equity, real assets, venture |
| Transaction Type |
Platform acquisition, add-on, growth investment, refinancing, IPO, secondary |
| Deal Stage |
Preliminary screening, LOI stage, final IC, post-close retrospective |
| Deal Size / Check Size |
Enterprise value, equity check, total capitalization |
| Source of Deal |
Proprietary, auction, banker-intermediated, inbound |
Audience & Format
| Audience |
Primary Focus |
Tone |
Length |
| PE Investment Committee |
Returns (IRR/MOIC), value creation levers, downside protection |
Direct, conviction-driven |
15-25 pp |
| IB Deal Team / Fairness Opinion |
Execution feasibility, valuation support, market context |
Analytical, balanced |
10-15 pp |
| Credit Committee |
Downside protection, coverage ratios, collateral, recovery analysis |
Conservative, stress-test-oriented |
12-20 pp |
| Board of Directors |
Strategic rationale, competitive positioning, governance |
Accessible, strategic |
8-12 pp |
| Growth Equity / Venture |
Market size, unit economics, founder quality, path to scale |
Forward-looking, thesis-driven |
10-15 pp |
Source Materials Checklist
GATE: If asset class, audience, or deal stage is unconfirmed, STOP and clarify. Do not draft.
Workflow
Step 1: Thesis Construction
Articulate the investment thesis as three pillars — three independent reasons this investment should generate returns. Each pillar must be:
- Specific — not "strong market position" but "45% share in a $2B TAM with 10-year contracts covering 70% of revenue"
- Falsifiable — state the condition that would invalidate the pillar
- Supported — cite the diligence source or data point
Pillar [N]: [One-line statement]
Supporting evidence: [2-3 data points with sources]
Key assumption: [What must remain true]
Falsification trigger: [What would break this pillar]
Step 2: Pre-Mortem Exercise
Before writing the bull case, write the bear case. Describe in 3-5 sentences the scenario where this investment fails and capital is impaired. This is a narrative of how things go wrong — not a risk factor list. This forces intellectual honesty and informs the Risk Factors section.
Step 3: Financial Analysis Build
Construct the financial narrative in this order:
| Component |
Content |
Key Outputs |
| Historical Analysis |
3-5 year income statement, balance sheet, cash flow trends |
Revenue CAGR, margin trajectory, capex intensity, FCF conversion |
| Normalization |
Adjustments for one-time items, owner compensation, related-party transactions |
Adjusted EBITDA bridge |
| Projections |
Management case vs. sponsor/analyst case |
Revenue build, margin assumptions, working capital, capex |
| Key Assumptions Table |
Line-item assumptions with justification |
Explicit list: growth rate, margin, churn, capex, tax rate |
| Sensitivity Analysis |
2-variable matrix on key value drivers |
IRR/MOIC sensitivity to revenue growth × exit multiple (PE) or price target sensitivity (public) |
Step 4: Valuation
Apply methods appropriate to the asset class. Valuation must produce a range, not a point estimate — present base / bull / bear with the assumptions that differ across scenarios.
| Method |
When to Use |
Key Inputs |
| DCF |
All situations; primary for growth assets |
WACC, terminal growth, FCF projections |
| Comparable Companies |
Public equity, benchmarking private valuations |
EV/EBITDA, EV/Revenue, P/E multiples from peer set |
| Precedent Transactions |
M&A, PE acquisitions |
Transaction multiples, control premiums |
| LBO Analysis |
PE acquisitions, leveraged situations |
Entry multiple, leverage, operating improvements, exit multiple, hold period |
| Sum-of-Parts |
Conglomerates, multi-segment businesses |
Segment-level multiples applied independently |
| Dividend Discount Model |
Yield-oriented investments, REITs, infrastructure |
Dividend growth rate, cost of equity |
Use at least two methods and reconcile the resulting range.
Step 5: Risk Framework
Structure risks into five categories. Each risk gets a probability assessment and a specific mitigant — not a generic disclaimer.
| Risk Category |
Examples |
Mitigant Type |
| Market Risk |
Cyclicality, demand shift, commodity exposure |
Hedging, contract structure, diversification |
| Execution Risk |
Integration failure, management capacity, operational complexity |
Retention packages, playbook from prior deals, phased integration |
| Management Risk |
Key-person dependency, alignment, track record gaps |
Incentive structure, board governance, succession planning |
| Regulatory Risk |
Antitrust, licensing, environmental, data privacy [VERIFY] |
Legal diligence, compliance programs, regulatory pre-clearance |
| Financial Risk |
Leverage, liquidity, covenant compliance, FX exposure |
Debt structure, cash reserves, hedging instruments |
Each risk entry must include: (1) specific risk description, (2) probability (High/Medium/Low), (3) impact (High/Medium/Low), (4) mitigant action or structure, (5) residual exposure after mitigant.
Step 6: Source of Edge
Every memo must answer: Why does this opportunity exist, and why are we the right capital to deploy?
- Proprietary access — relationship-sourced, not auctioned
- Information asymmetry — diligence has surfaced insight the market lacks
- Timing — cyclical dislocation, motivated seller, regulatory window
- Structural — complexity discount, carve-out, cross-border friction
- Operational — portfolio company synergies, sector expertise, management bench
If no clear edge exists, state so explicitly. "Market-clearing price in a competitive auction" is a valid statement — pretending otherwise is not.
Step 7: Draft Assembly
- Executive Summary first — written last, positioned first. One page maximum. Must contain: what, why, how much, expected return, key risk, recommendation.
- Thesis before data — lead with the argument, then support with evidence. Do not force the reader to assemble the thesis from scattered data points.
- Tables over paragraphs — financial data, comparables, and risk matrices belong in tables, not prose.
- Flag uncertainty — mark unverified figures with
[VERIFY], assumptions with [ASSUMPTION], and management-provided projections with [MGMT].
- Recommendation must be unambiguous — "Invest at $X valuation with conditions Y and Z" or "Pass because [reason]" or "Requires additional diligence on [specific items] before decision."
Step 8: Post-Draft Alignment
Before delivering, confirm with the requesting party:
| Check |
Question |
| Thesis Alignment |
"Does the three-pillar thesis match your conviction? Any pillar you would reframe?" |
| Return Expectations |
"Are the return assumptions (entry multiple, growth, exit) consistent with your base case?" |
| Risk Calibration |
"Are there risks from diligence that are missing or under-weighted?" |
| Audience Fit |
"Is the depth and tone appropriate for the target audience?" |
| Data Freshness |
"Are the financials and market data current as of the intended IC date?" |
| Recommendation Strength |
"Is the recommendation correctly calibrated to your conviction level?" |
GATE: If thesis, return assumptions, or recommendation are misaligned, revise before delivery. Do not submit a memo the deal lead has not approved.
Output
The final investment memo should contain these sections in order:
- Executive Summary — one page; thesis, deal terms, expected returns, key risk, recommendation
- Investment Thesis — three pillars with falsification triggers
- Company / Asset Overview — business description, history, market position
- Industry & Market Analysis — TAM/SAM, competitive landscape, secular trends
- Financial Analysis — historical performance, normalization, projections, assumptions table
- Valuation — multi-method analysis with reconciled range (base/bull/bear)
- Risk Factors — five-category framework with probability, impact, mitigant, residual exposure
- Source of Edge — why this opportunity exists and our right to win
- Recommendation — unambiguous invest/pass/conditional with specific terms
Tag conventions: [VERIFY] for unconfirmed data, [ASSUMPTION] for forward-looking estimates, [MGMT] for management-sourced projections. Use consistent units ($ in millions unless stated) throughout.
Quality Checks
Structural Completeness
Financial Rigor
Risk Integrity
Drafting Standards
Reference Files
| File |
Description |
references/MEMO-TEMPLATE.md |
Structural template for investment memoranda with all nine sections and appendices |
1---2name: drafting-investment-memos3description: Creates structured investment memoranda with business description, financial analysis, valuation, and risk assessment for deal review. Use when writing investment memos, preparing deal summaries, or documenting investment recommendations.4---5# Drafting Investment Memos
6
7Investment memos are the core decision document for deploying capital. They synthesize diligence into a structured argument that enables an investment committee, board, or deal team to make a go/no-go decision with full awareness of the thesis, the risks, and the expected returns. The memo is not a summary — it is the decision artifact.
8
9## When To Use
10
11- Preparing a deal for investment committee review (screening, LOI, or final IC)
12- Writing a deal summary or recommendation for board presentation
13- Documenting the investment rationale for a platform acquisition, add-on, growth investment, refinancing, IPO, or secondary transaction
14- Creating a post-close retrospective memo evaluating realized vs. projected returns
15- Supporting a fairness opinion or strategic alternatives analysis with structured deal analysis
16
17## Inputs To Gather
18
19Confirm ALL of the following before drafting. Do not proceed with defaults — wrong audience framing invalidates the entire draft.
20
21### Deal Context (All Required)
22
23| Field | Notes |
24|---|---|
25| Company/Asset Name | Legal name + common name if different |
26| Asset Class | Private equity, growth equity, credit, public equity, real assets, venture |
27| Transaction Type | Platform acquisition, add-on, growth investment, refinancing, IPO, secondary |
28| Deal Stage | Preliminary screening, LOI stage, final IC, post-close retrospective |
29| Deal Size / Check Size | Enterprise value, equity check, total capitalization |
30| Source of Deal | Proprietary, auction, banker-intermediated, inbound |
31
32### Audience & Format
33
34| Audience | Primary Focus | Tone | Length |
35|---|---|---|---|
36| PE Investment Committee | Returns (IRR/MOIC), value creation levers, downside protection | Direct, conviction-driven | 15-25 pp |
37| IB Deal Team / Fairness Opinion | Execution feasibility, valuation support, market context | Analytical, balanced | 10-15 pp |
38| Credit Committee | Downside protection, coverage ratios, collateral, recovery analysis | Conservative, stress-test-oriented | 12-20 pp |
39| Board of Directors | Strategic rationale, competitive positioning, governance | Accessible, strategic | 8-12 pp |
40| Growth Equity / Venture | Market size, unit economics, founder quality, path to scale | Forward-looking, thesis-driven | 10-15 pp |
41
42### Source Materials Checklist
43
44- [ ] CIM / Management Presentation
45- [ ] Historical financials (3-5 years minimum)
46- [ ] Management projections / budget
47- [ ] Quality of Earnings report (if available)
48- [ ] Industry research / market reports
49- [ ] Comparable company data
50- [ ] Precedent transaction data
51- [ ] Legal/regulatory diligence findings
52- [ ] Customer/commercial diligence findings
53- [ ] ESG/compliance considerations
54
55> **GATE**: If asset class, audience, or deal stage is unconfirmed, STOP and clarify. Do not draft.
56
57## Workflow
58
59### Step 1: Thesis Construction
60
61Articulate the investment thesis as **three pillars** — three independent reasons this investment should generate returns. Each pillar must be:
62
63- **Specific** — not "strong market position" but "45% share in a $2B TAM with 10-year contracts covering 70% of revenue"
64- **Falsifiable** — state the condition that would invalidate the pillar
65- **Supported** — cite the diligence source or data point
66
67```
68Pillar [N]: [One-line statement]
69Supporting evidence: [2-3 data points with sources]
70Key assumption: [What must remain true]
71Falsification trigger: [What would break this pillar]
72```
73
74### Step 2: Pre-Mortem Exercise
75
76Before writing the bull case, write the bear case. Describe in 3-5 sentences the scenario where this investment fails and capital is impaired. This is a narrative of how things go wrong — not a risk factor list. This forces intellectual honesty and informs the Risk Factors section.
77
78### Step 3: Financial Analysis Build
79
80Construct the financial narrative in this order:
81
82| Component | Content | Key Outputs |
83|---|---|---|
84| Historical Analysis | 3-5 year income statement, balance sheet, cash flow trends | Revenue CAGR, margin trajectory, capex intensity, FCF conversion |
85| Normalization | Adjustments for one-time items, owner compensation, related-party transactions | Adjusted EBITDA bridge |
86| Projections | Management case vs. sponsor/analyst case | Revenue build, margin assumptions, working capital, capex |
87| Key Assumptions Table | Line-item assumptions with justification | Explicit list: growth rate, margin, churn, capex, tax rate |
88| Sensitivity Analysis | 2-variable matrix on key value drivers | IRR/MOIC sensitivity to revenue growth × exit multiple (PE) or price target sensitivity (public) |
89
90### Step 4: Valuation
91
92Apply methods appropriate to the asset class. **Valuation must produce a range, not a point estimate** — present base / bull / bear with the assumptions that differ across scenarios.
93
94| Method | When to Use | Key Inputs |
95|---|---|---|
96| DCF | All situations; primary for growth assets | WACC, terminal growth, FCF projections |
97| Comparable Companies | Public equity, benchmarking private valuations | EV/EBITDA, EV/Revenue, P/E multiples from peer set |
98| Precedent Transactions | M&A, PE acquisitions | Transaction multiples, control premiums |
99| LBO Analysis | PE acquisitions, leveraged situations | Entry multiple, leverage, operating improvements, exit multiple, hold period |
100| Sum-of-Parts | Conglomerates, multi-segment businesses | Segment-level multiples applied independently |
101| Dividend Discount Model | Yield-oriented investments, REITs, infrastructure | Dividend growth rate, cost of equity |
102
103Use at least two methods and reconcile the resulting range.
104
105### Step 5: Risk Framework
106
107Structure risks into five categories. Each risk gets a probability assessment and a specific mitigant — not a generic disclaimer.
108
109| Risk Category | Examples | Mitigant Type |
110|---|---|---|
111| Market Risk | Cyclicality, demand shift, commodity exposure | Hedging, contract structure, diversification |
112| Execution Risk | Integration failure, management capacity, operational complexity | Retention packages, playbook from prior deals, phased integration |
113| Management Risk | Key-person dependency, alignment, track record gaps | Incentive structure, board governance, succession planning |
114| Regulatory Risk | Antitrust, licensing, environmental, data privacy [VERIFY] | Legal diligence, compliance programs, regulatory pre-clearance |
115| Financial Risk | Leverage, liquidity, covenant compliance, FX exposure | Debt structure, cash reserves, hedging instruments |
116
117Each risk entry must include: (1) specific risk description, (2) probability (High/Medium/Low), (3) impact (High/Medium/Low), (4) mitigant action or structure, (5) residual exposure after mitigant.
118
119### Step 6: Source of Edge
120
121Every memo must answer: **Why does this opportunity exist, and why are we the right capital to deploy?**
122
123- **Proprietary access** — relationship-sourced, not auctioned
124- **Information asymmetry** — diligence has surfaced insight the market lacks
125- **Timing** — cyclical dislocation, motivated seller, regulatory window
126- **Structural** — complexity discount, carve-out, cross-border friction
127- **Operational** — portfolio company synergies, sector expertise, management bench
128
129If no clear edge exists, state so explicitly. "Market-clearing price in a competitive auction" is a valid statement — pretending otherwise is not.
130
131### Step 7: Draft Assembly
132
133- **Executive Summary first** — written last, positioned first. One page maximum. Must contain: what, why, how much, expected return, key risk, recommendation.
134- **Thesis before data** — lead with the argument, then support with evidence. Do not force the reader to assemble the thesis from scattered data points.
135- **Tables over paragraphs** — financial data, comparables, and risk matrices belong in tables, not prose.
136- **Flag uncertainty** — mark unverified figures with `[VERIFY]`, assumptions with `[ASSUMPTION]`, and management-provided projections with `[MGMT]`.
137- **Recommendation must be unambiguous** — "Invest at $X valuation with conditions Y and Z" or "Pass because [reason]" or "Requires additional diligence on [specific items] before decision."
138
139### Step 8: Post-Draft Alignment
140
141Before delivering, confirm with the requesting party:
142
143| Check | Question |
144|---|---|
145| Thesis Alignment | "Does the three-pillar thesis match your conviction? Any pillar you would reframe?" |
146| Return Expectations | "Are the return assumptions (entry multiple, growth, exit) consistent with your base case?" |
147| Risk Calibration | "Are there risks from diligence that are missing or under-weighted?" |
148| Audience Fit | "Is the depth and tone appropriate for the target audience?" |
149| Data Freshness | "Are the financials and market data current as of the intended IC date?" |
150| Recommendation Strength | "Is the recommendation correctly calibrated to your conviction level?" |
151
152> **GATE**: If thesis, return assumptions, or recommendation are misaligned, revise before delivery. Do not submit a memo the deal lead has not approved.
153
154## Output
155
156The final investment memo should contain these sections in order:
157
1581. **Executive Summary** — one page; thesis, deal terms, expected returns, key risk, recommendation
1592. **Investment Thesis** — three pillars with falsification triggers
1603. **Company / Asset Overview** — business description, history, market position
1614. **Industry & Market Analysis** — TAM/SAM, competitive landscape, secular trends
1625. **Financial Analysis** — historical performance, normalization, projections, assumptions table
1636. **Valuation** — multi-method analysis with reconciled range (base/bull/bear)
1647. **Risk Factors** — five-category framework with probability, impact, mitigant, residual exposure
1658. **Source of Edge** — why this opportunity exists and our right to win
1669. **Recommendation** — unambiguous invest/pass/conditional with specific terms
167
168Tag conventions: `[VERIFY]` for unconfirmed data, `[ASSUMPTION]` for forward-looking estimates, `[MGMT]` for management-sourced projections. Use consistent units ($ in millions unless stated) throughout.
169
170## Quality Checks
171
172### Structural Completeness
173- [ ] All nine sections present
174- [ ] Executive summary fits on one page
175- [ ] Investment thesis states exactly three pillars with falsification triggers
176- [ ] Pre-mortem scenario included
177- [ ] Source of edge explicitly stated
178
179### Financial Rigor
180- [ ] Historical financials cover 3+ years
181- [ ] Adjusted EBITDA bridge included with clear add-backs
182- [ ] Projection assumptions listed individually with justification
183- [ ] Sensitivity table covers at least two variables
184- [ ] Valuation uses 2+ methods with reconciled range
185- [ ] Returns analysis appropriate to asset class (IRR/MOIC for PE, price target for public)
186
187### Risk Integrity
188- [ ] All five risk categories addressed
189- [ ] Each risk has probability, impact, mitigant, and residual exposure
190- [ ] Pre-mortem narrative is distinct from risk factor list
191- [ ] No generic/boilerplate risk language — every risk is specific to this deal
192
193### Drafting Standards
194- [ ] `[VERIFY]` / `[ASSUMPTION]` / `[MGMT]` tags applied where appropriate
195- [ ] Consistent units, date formats, and decimal precision throughout
196- [ ] No hedged or ambiguous recommendation
197- [ ] EBITDA definition (adjusted vs. reported) stated once and used consistently
198- [ ] Scope limitations noted — e.g., memo based on CIM without QofE should say so
199- [ ] Appropriate disclaimers for compliance-sensitive outputs [VERIFY]
200
201## Reference Files
202
203| File | Description |
204|---|---|
205| `references/MEMO-TEMPLATE.md` | Structural template for investment memoranda with all nine sections and appendices |